|
|
As of 7 July 2022,
- 7,629 confirmed cases of monkeypox from 61 countries, areas, and territories globally: 83% in the European Region, 14% in the Region of the Americas, 2% in the Africa Region, <1% in the Eastern Mediterranean Region, and <1% in the Western Pacific Region. Three deaths have been reported in Nigeria (1) and the Central African Republic (2).
- 1,185 confirmed cases from 15 countries and territories in the Americas: Argentina (6 cases), the Bahamas (1 case), Brazil (142 cases), Canada (370 cases), Chile (8 cases), Colombia (5 cases), the Dominican Republic (1 case), Ecuador (1 case), Jamaica (1 case), Mexico (27 cases), Panama (1 case), Peru (15 cases), Puerto Rico (1 case), the United States of America (605 cases), and the Bolivarian Republic of Venezuela (1 case).
- 473 additional confirmed cases and 4 additional countries (the Dominican Republic, Ecuador, Jamaica, and Panama) reporting confirmed cases since the last Situation Report on 30 June 2022.
- The majority of confirmed cases with available demographic information are male (99%), 79% are aged 25 to 45 years old, and most self-identify as men who have sex with other men.
- Continued increase in cases with no history of travel. Almost 60% of cases in the Americas with available information did not report a recent history of travel.
- In a 6 July 2022 media briefing, the WHO Director-General stated he is planning to reconvene the IHR Emergency Committee for monkeypox during the week of 18 July, or sooner if needed.
- On 6 July 2022, WHO published the External Situation Report #1 for monkeypox. The risk is assessed as Moderate at the global level, High in the WHO European Region, and Moderate in the other WHO Regions.
|
